For example, in patients at early symptomatic stages, when cognitive impairment is first detected, enhancing physiological apoptotic pathways using Bcl-2 or Bcl-xL inhibitors, or promoting the cell competition pathway described here, may have strikingly beneficial effects. Here, BCL2L1 is linked to Cognitive impairment.